Drug Information

Drug General Information
Drug ID
D0K7XU
Former ID
DNC011685
Drug Name
N-Hydroxy-4-naphthalen-2-yl-benzamide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [532087]
Structure
Download
2D MOL

3D MOL
Formula
C17H13NO2
Canonical SMILES
C1=CC=C2C=C(C=CC2=C1)C3=CC=C(C=C3)C(=O)NO
InChI
1S/C17H13NO2/c19-17(18-20)14-8-5-13(6-9-14)16-10-7-12-3-1-2-4-15(12)11-16/h1-11,20H,(H,18,19)
InChIKey
CYVBBSVZKCLSIR-UHFFFAOYSA-N
PubChem Compound ID
44369651
Target and Pathway
Target(s) Arachidonate 5-lipoxygenase Target Info Inhibitor [532087]
BioCyc Pathway Aspirin-triggered lipoxin biosynthesis
Resolvin D biosynthesis
Leukotriene biosynthesis
Lipoxin biosynthesis
Aspirin triggered resolvin D biosynthesis
Aspirin triggered resolvin E biosynthesis
KEGG Pathway Arachidonic acid metabolism
Metabolic pathways
Serotonergic synapse
Ovarian steroidogenesis
Toxoplasmosis
NetPath Pathway IL4 Signaling Pathway
PathWhiz Pathway Arachidonic Acid Metabolism
WikiPathways Vitamin D Receptor Pathway
Arachidonic acid metabolism
Eicosanoid Synthesis
Selenium Micronutrient Network
References
Ref 532087J Med Chem. 1990 Mar;33(3):992-8.Hydroxamic acid inhibitors of 5-lipoxygenase: quantitative structure-activity relationships.
Ref 532087J Med Chem. 1990 Mar;33(3):992-8.Hydroxamic acid inhibitors of 5-lipoxygenase: quantitative structure-activity relationships.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.